Cargando…
How inhaled corticosteroids target inflammation in COPD
Inhaled corticosteroids (ICS) are the most commonly used anti-inflammatory drugs for the treatment of COPD. COPD has been previously described as a “corticosteroid-resistant” condition, but current clinical trial evidence shows that selected COPD patients, namely those with increased exacerbation ri...
Autores principales: | Lea, Simon, Higham, Andrew, Beech, Augusta, Singh, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582931/ https://www.ncbi.nlm.nih.gov/pubmed/37852657 http://dx.doi.org/10.1183/16000617.0084-2023 |
Ejemplares similares
-
Exhaled nitric oxide, eosinophils and current smoking in COPD patients
por: Higham, Andrew, et al.
Publicado: (2023) -
Corticosteroid effects on COPD alveolar macrophages: Dependency on cell culture methodology
por: Higham, Andrew, et al.
Publicado: (2014) -
The effects of corticosteroids on COPD lung macrophages: a pooled analysis
por: Higham, Andrew, et al.
Publicado: (2015) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021) -
Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)